Cargando…
Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report
BACKGROUND: Mycetoma is a chronic granulomatous subcutaneous infection caused by anaerobic pseudofilamentous bacteria or fungi. It is commonly prevalent in tropical and subtropical countries. Men are more susceptible to the disease due to greater participation in agricultural works. Mycetoma commonl...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656693/ https://www.ncbi.nlm.nih.gov/pubmed/33176717 http://dx.doi.org/10.1186/s12879-020-05552-z |
_version_ | 1783608402953371648 |
---|---|
author | Izri, Arezki Aljundi, Mohanad Billard-Pomares, Typhaine Fofana, Youssouf Marteau, Anthony Ferreira, Theo Ghelfenstein Brun, Sophie Caux, Frederic Akhoundi, Mohammad |
author_facet | Izri, Arezki Aljundi, Mohanad Billard-Pomares, Typhaine Fofana, Youssouf Marteau, Anthony Ferreira, Theo Ghelfenstein Brun, Sophie Caux, Frederic Akhoundi, Mohammad |
author_sort | Izri, Arezki |
collection | PubMed |
description | BACKGROUND: Mycetoma is a chronic granulomatous subcutaneous infection caused by anaerobic pseudofilamentous bacteria or fungi. It is commonly prevalent in tropical and subtropical countries. Men are more susceptible to the disease due to greater participation in agricultural works. Mycetoma commonly involves lower extremities, wherein untreated cases lead to aggressive therapeutic choices, such as amputation of the affected body organs and consequently lifelong disability. CASE PRESENTATION: In this report, we present the rare case of a 58-year-old man, originally from Algeria with a left foot chronic tumefaction of 5 years. In the initial clinical examination, mycetoma was diagnosed based on tumefaction and the presence of multiple sinuses with the emission of white grains. The latter was observed via direct examination. The histopathological analysis demonstrated an actinomycetoma caused by bacteria, as the etiological agent. Imaging showed a bone involvement with osteolysis at the levels of 2nd to 4th metatarsal diaphysis. The mycological and bacterial cultures were both negative. For an accurate diagnosis, the obtained grains were subjected to molecular analysis, targeting the 16S-rDNA gene. Molecular identification yielded Actinomadura madurae as the causal agent, and 800/160 mg of trimethoprim/sulfamethoxazole was prescribed twice a day for 1 year, as a treatment. CONCLUSION: Considering low information about this disease, especially in non-endemic areas, it is of high importance to enhance the knowledge and awareness of clinicians and healthcare providers, in particular in the countries with immigration issues. |
format | Online Article Text |
id | pubmed-7656693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76566932020-11-12 Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report Izri, Arezki Aljundi, Mohanad Billard-Pomares, Typhaine Fofana, Youssouf Marteau, Anthony Ferreira, Theo Ghelfenstein Brun, Sophie Caux, Frederic Akhoundi, Mohammad BMC Infect Dis Case Report BACKGROUND: Mycetoma is a chronic granulomatous subcutaneous infection caused by anaerobic pseudofilamentous bacteria or fungi. It is commonly prevalent in tropical and subtropical countries. Men are more susceptible to the disease due to greater participation in agricultural works. Mycetoma commonly involves lower extremities, wherein untreated cases lead to aggressive therapeutic choices, such as amputation of the affected body organs and consequently lifelong disability. CASE PRESENTATION: In this report, we present the rare case of a 58-year-old man, originally from Algeria with a left foot chronic tumefaction of 5 years. In the initial clinical examination, mycetoma was diagnosed based on tumefaction and the presence of multiple sinuses with the emission of white grains. The latter was observed via direct examination. The histopathological analysis demonstrated an actinomycetoma caused by bacteria, as the etiological agent. Imaging showed a bone involvement with osteolysis at the levels of 2nd to 4th metatarsal diaphysis. The mycological and bacterial cultures were both negative. For an accurate diagnosis, the obtained grains were subjected to molecular analysis, targeting the 16S-rDNA gene. Molecular identification yielded Actinomadura madurae as the causal agent, and 800/160 mg of trimethoprim/sulfamethoxazole was prescribed twice a day for 1 year, as a treatment. CONCLUSION: Considering low information about this disease, especially in non-endemic areas, it is of high importance to enhance the knowledge and awareness of clinicians and healthcare providers, in particular in the countries with immigration issues. BioMed Central 2020-11-11 /pmc/articles/PMC7656693/ /pubmed/33176717 http://dx.doi.org/10.1186/s12879-020-05552-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Izri, Arezki Aljundi, Mohanad Billard-Pomares, Typhaine Fofana, Youssouf Marteau, Anthony Ferreira, Theo Ghelfenstein Brun, Sophie Caux, Frederic Akhoundi, Mohammad Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report |
title | Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report |
title_full | Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report |
title_fullStr | Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report |
title_full_unstemmed | Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report |
title_short | Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report |
title_sort | molecular identification of actinomadura madurae isolated from a patient originally from algeria; observations from a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656693/ https://www.ncbi.nlm.nih.gov/pubmed/33176717 http://dx.doi.org/10.1186/s12879-020-05552-z |
work_keys_str_mv | AT izriarezki molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport AT aljundimohanad molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport AT billardpomarestyphaine molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport AT fofanayoussouf molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport AT marteauanthony molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport AT ferreiratheoghelfenstein molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport AT brunsophie molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport AT cauxfrederic molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport AT akhoundimohammad molecularidentificationofactinomaduramaduraeisolatedfromapatientoriginallyfromalgeriaobservationsfromacasereport |